(Q44710572)

5 December 2017

title

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy (English)

1 reference

5 December 2017

0 references

0 references

8

Yair Lotan

1 reference

5 December 2017

2

Pierre I Karakiewicz

1 reference

5 December 2017

1

Shahrokh F Shariat

1 reference

5 December 2017

7

Arthur I Sagalowsky

1 reference

5 December 2017

4

Seth P Lerner

1 reference

5 December 2017

6

Richard J Cote

1 reference

5 December 2017

3

Raheela Ashfaq

1 reference

5 December 2017

5

Ganesh S Palapattu

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

5 December 2017

1 reference

5 December 2017

volume

112

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

315-325

1 reference

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

Bladder cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Cystectomy for bladder cancer: a contemporary series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Nomograms provide improved accuracy for predicting survival after radical cystectomy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Precystectomy nomogram for prediction of advanced bladder cancer stage.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Regression modeling of competing crude failure probabilities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Evaluating the yield of medical tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Microarrays as cancer keys: an array of possibilities.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Tissue microarrays: bridging the gap between research and the clinic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23162

7 January 2021

Identifiers

DOI

10.1002/CNCR.23162

1 reference

5 December 2017

1 reference